Skip to content
by Legal Desire
7 June 2026

Latham & Watkins Advises Bridgepoint in Acquisition of Obagi Medical From Waldencast

Advising firms

Deal team

14 lawyers named
LawyerFirmSeniorityPracticeOffice
Jane Greyf Lead Latham & Watkins LLP Partner corporate New York
David Allinson Lead Latham & Watkins LLP Partner corporate New York
Olivier du Mottay Latham & Watkins LLP Partner corporate Paris
Said Bakir Latham & Watkins LLP Associate corporate Not stated
Meghan McDuff Latham & Watkins LLP Associate corporate Not stated
Anny Yang Latham & Watkins LLP Associate corporate Not stated
Eric Kamerman Latham & Watkins LLP Partner tax New York
Jacob Nagelberg Latham & Watkins LLP Associate tax Not stated
Steven Betensky Latham & Watkins LLP Partner intellectual property New York
Alan Kim Latham & Watkins LLP Associate intellectual property Not stated
Adam Kestenbaum Latham & Watkins LLP Partner benefits and compensation Washington, D.C.
Laura Szarmach Latham & Watkins LLP Counsel benefits and compensation Washington, D.C.
Shaun Thompson Latham & Watkins LLP Counsel benefits and compensation London
Kevin Matheny Latham & Watkins LLP Associate benefits and compensation Not stated

11 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
Not stated
What the figure measures
Not stated
Client
BridgepointBuy-side
Counterparties
Waldencast plc (Sell-side)